The role of natural killer cells in human disease
- 1 October 1989
- journal article
- review article
- Published by Elsevier BV in Clinical Immunology and Immunopathology
- Vol. 53 (1), 1-23
- https://doi.org/10.1016/0090-1229(89)90096-2
Abstract
No abstract availableThis publication has 99 references indexed in Scilit:
- Deficient interleukin-2-activated killer cell cytotoxicity in patients with systemic lupus erythematosusClinical Immunology and Immunopathology, 1989
- Characteristics and uses of natural killer cellsImmunology Today, 1988
- Role of interleukin 2 in inducing normalization of natural killer activity in systemic lupus erythematosusClinical Immunology and Immunopathology, 1988
- A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 AloneNew England Journal of Medicine, 1987
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Human large granular lymphocytes induce immunoglobulin synthesis after bone marrow transplantationEuropean Journal of Immunology, 1987
- Familial occurrence of breast cancer is associated with reduced natural killer cytotoxicityBreast Cancer Research and Treatment, 1986
- Natural killer (NK) cell activity and its in vitro response to interferon‐α(Le) in chronic liver diseases and hepatocellular carcinomaLiver International, 1986
- Phenotypical and functional analysis of natural killer cells in sarcoidosisClinical Immunology and Immunopathology, 1985
- Natural Killer Cell Activity During Premedication, Anaesthesia and SurgeryActa Anaesthesiologica Scandinavica, 1983